Cargando…

Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma

SIMPLE SUMMARY: Gut dysbiosis with an impaired intestinal barrier is differentially associated with liver diseases and, therefore, alters the systemic immunological milieu through the gut–liver axis. As a result, it plays a prominent role in liver inflammation, fibrosis, and carcinogenesis. Here, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Ming-Wei, Chu, Yu-De, Hsu, Chao-Wei, Chen, Yi-Cheng, Liang, Kung-Hao, Yeh, Chau-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818216/ https://www.ncbi.nlm.nih.gov/pubmed/36612207 http://dx.doi.org/10.3390/cancers15010210

Ejemplares similares

Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study
por: Liang, Kung-Hao, et al.
Publicado: (2020)

Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma
por: Ding,, Dongxiao, et al.
Publicado: (2023)

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD
por: Zhang, Yuwei, et al.
Publicado: (2020)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

Corrigendum: Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2021)

Hepatitis B Virus Covalently Closed Circular DNA Predicts Postoperative Liver Cancer Metastasis Independent of Virological Suppression
por: Hsu, Chao-Wei, et al.
Publicado: (2021)

Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis
por: Shen, Qianyun, et al.
Publicado: (2022)

A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients
por: Huang, Ya-Hui, et al.
Publicado: (2017)

Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan
por: Hung, Tsung-Hsing, et al.
Publicado: (2017)

Multi-omics of the esophageal microenvironment identifies signatures associated with progression of Barrett’s esophagus
por: Deshpande, Nandan P., et al.
Publicado: (2021)

Multi-omic network signatures of disease
por: Gibbs, David L., et al.
Publicado: (2014)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma
por: Effenberger, Maria, et al.
Publicado: (2023)

“Multi-Omics” Analyses of the Development and Function of Natural Killer Cells
por: Zhou, Yonggang, et al.
Publicado: (2017)

Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells
por: Xie, Qi, et al.
Publicado: (2017)

A Multi-Cohort and Multi-Omics Meta-Analysis Framework to Identify Network-Based Gene Signatures
por: Shafi, Adib, et al.
Publicado: (2019)

Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019)

Multi-omic signatures identify pan-cancer classes of tumors beyond tissue of origin
por: González-Reymúndez, Agustín, et al.
Publicado: (2020)

Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis
por: Chen, Xingyu, et al.
Publicado: (2021)

Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal Melanoma
por: Mo, Qianxing, et al.
Publicado: (2021)

Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
por: Portokallidou, Konstantina, et al.
Publicado: (2023)

Single-Cell Analyses in the Multi-omics Era
Publicado: (2020)

Development of bioinformatics and multi-omics analyses in organoids
por: Ha, Doyeon, et al.
Publicado: (2023)

Multi-Omics Analyses Characterize the Gut Microbiome and Metabolome Signatures of Soldiers Under Sustained Military Training
por: Shi, Yifan, et al.
Publicado: (2022)

Pan‐cancer analyses reveal multi‐omic signatures and clinical implementations of the forkhead‐box gene family
por: Bi, Xiaoman, et al.
Publicado: (2023)

Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma
por: Cui, Dawei, et al.
Publicado: (2021)

Multi-omic and multi-species meta-analyses of nicotine consumption
por: Palmer, Rohan H. C., et al.
Publicado: (2021)

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
por: Ao, Lu, et al.
Publicado: (2016)

Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures
por: Xiong, Yi, et al.
Publicado: (2020)

Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network
por: Wang, Zhihui, et al.
Publicado: (2021)

Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis
por: Ouyang, Xiao, et al.
Publicado: (2020)

Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021)

The Need for Multi-Omics Biomarker Signatures in Precision Medicine
por: Olivier, Michael, et al.
Publicado: (2019)

Multi-omics signatures of the human early life exposome
por: Maitre, Léa, et al.
Publicado: (2022)

Spatial multi-omics analyses of the tumor immune microenvironment
por: Hsieh, Wan-Chen, et al.
Publicado: (2022)

UGT2B28 genomic variation is associated with hepatitis B e-antigen seroconversion in response to antiviral therapy
por: Liang, Kung-Hao, et al.
Publicado: (2016)

Integrating multiple ‘omics’ analyses identifies serological protein biomarkers for preeclampsia
por: Liu, Linda Y, et al.
Publicado: (2013)

Multi-Omics Approaches Identify Necroptosis‑Related Prognostic Signature and Associated Regulatory Axis in Cervical Cancer
por: Zhan, JuanMei, et al.
Publicado: (2022)

Multi-Omic Analyses of the m(5)C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nb2idcub8krdl8ibkv9qejh52r